Advances in Coronary Microvascular Dysfunction and Metabolic Syndrome

Abstract

Coronary microvascular dysfunction (CMD) and metabolic syndrome (MetS) have attracted much attention recently due to the adverse effects on cardiovascular system. CMD is a potential factor leading to myocardial ischemia, which is closely related to the occurrence, progression and poor prognosis of cardiovascular diseases. MetS is a group of metabolic diseases caused by a combination of genetic and environmental factors. There is an association between CMD and MetS, understanding the complex interactions between the two diseases is essential for developing effective prevention and treatment strategies. This article aims to review the development of MetS and CMD, and the relationship of the components of MetS with CMD, as well as the diagnosis, treatment and future research directions of these diseases.

Keywords

• coronary heart diseases|coronary microvascular dysfunction|metabolic syndrome|review|editorial